Results 1 to 10 of about 88,988 (279)
Journal of Medical Case Reports, 2021 Background Cystoid macular edema is a rare, vision-threatening side effect of the taxane family of anticancer agents. There is no established treatment or standard treatment protocol for taxane-related cystoid macular edema.
Mitsuru Otsubo +3 more
doaj +1 more source
Development of Clinical and Morphometric Classification of Macular Edema in Retinal Vein Occlusions
Oftalʹmologiâ, 2022 Purpose. To study the morphometric features of macular edema in occlusions of the retinal veins, to determine and systematize the conditional gradations of the degrees of its severity.Patients and methods.
A. A. Fil, E. L. Sorokin, O. V. Kolenko
doaj +1 more source
Revista de la Facultad de Medicina, 2022 Introducción: La tomografía de coherencia óptica y la angiografía con fluoresceína son estudios de imagen oftalmológicas de gran utilidad para el diagnóstico de edema macular diabético.
María Alejandra Carías Morales +1 more
doaj +1 more source
Lurbinectedin improves macular edema in a case of central retinal vein occlusion
American Journal of Ophthalmology Case Reports, 2022 Purpose: To evaluate the response to lurbinectedin in a case of macular edema, secondary to central retinal vein occlusion (CRVO). Serial spectral domain optical coherence tomography (SD-OCT) scans were taken in a 70-year-old man with a 24-month history ...
Filippo Simona +5 more
doaj +1 more source
American Journal of Ophthalmology Case Reports, 2022 Purpose: To report a patient with resistant cystoid macular edema after an uneventful phacoemulsification cataract surgery who responded to subconjunctival interferon α2b injections.
Hossein Aghaei +2 more
doaj +1 more source
Macular edema after siponimod treatment for multiple sclerosis: a case report and literature review
BMC Neurology, 2023 Background As a modulator of the sphingosine 1-phosphate receptor, siponimod is administered as a therapeutic intervention for multiple sclerosis. A previous phase 3 study first reported siponimod-associated macular edema.
Qingsheng Li +3 more
doaj +1 more source
ASSOCIATION BETWEEN THE DEGREE OF DIABETIC RETINOPATHY AND DIABETIC MACULAR EDEMA
Jurnal Kedokteran Diponegoro, 2022 INTRODUCTION: WHO estimates more than 150 million diabetes patients worldwide. One of the complications of diabetes is diabetic retinopathy which is recognized as the leading cause of blindness in the working-age population and the cause of 12% of new ...
Andhika Guna Dharma +6 more
doaj +1 more source
Widening use of dexamethasone implant for the treatment of macular edema [PDF]
, 2017 Sustained-release intravitreal 0.7 mg dexamethasone (DEX) implant is approved in Europe for the treatment of macular edema related to diabetic retinopathy, branch retinal vein occlusion, central retinal vein occlusion, and non-infectious uveitis.
Avitabile T. +9 more
core +2 more sources
Laser treatment in diabetic retinopathy [PDF]
, 2007 Diabetic retinopathy is a leading cause of visual impairment and blindness in developed countries due to macular edema and proliferative diabetic retinopathy (PDR). For both complications laser treatment may offer proven therapy: the Diabetic Retinopathy
Akduman L +36 more
core +1 more source
An eighteen-month follow-up study on the effects of intravitreal dexamethasone implant in diabetic macular edema refractory to anti-VEGF therapy [PDF]
, 2016 AIM: To evaluate the long-term efficacy and safety of dexamethasone implants in subjects affected by diabetic macular edema (DME) resistant to anti-vascular endothelial growth factor (VEGF) therapy. METHODS: Thirty-two DME patients were enrolled.
Carnovale, Anna +7 more
core +1 more source